Osteoarthritis

P-18.3.2 - Evaluation of the Effect of Celecoxib on Cartilage in Vitro and in a Rat Osteoarthritis Model

Authors
Speaker
Disclosure
T.J.M. Welting and M.M.J. Caron are listed as inventor on patents: WO2017178251, WO2017178253 and US 20130123314. T.J.M. Welting, P.J. Emans and L.W. van Rhijn have shares in Chondropeptix BV.
Presentation Topic
Osteoarthritis
Poster Rating
 | 

Previous ePoster
P-18.2.9 - Patellofemoral Cartilage Lesions Treated with a Hyaluronan-based MACT Technique: Results at >15 years’ follow-up

Next ePosters
P-18.3.3 - Diabetes is Associated with an Increased Osteoarthritis Incidence in Non-Human Primates
P-18.3.6 - One Stage Cartilage Recycling Facilitated by Adipose MSCs Safe and Clinically Effective (RECLAIM)
P-18.3.8 - Surgical Management of the Young Degenerative Knee: “Power Ranking” the Options
P-18.3.9 - Does Sedentary Lifestyle Lead To Increased Osteoarthritis Among Diabetic Patients?
P-24.1.1 - Meniscus Repair in Selected Patients Over 60 can be Beneficial
P-24.1.5 - Novel Meniscal Scaffold Implantation for Irreparable Meniscal Tear Treatment: From Bench to Clinical Trial
P-24.2.1 - Comparison of Safety and Efficacy Between Autologous PRP and Cordonal PRP in the Treatment of Hip OA
P-24.2.2 - Labral Tear Management in Patients Aged 40 Years and Older Undergoing Primary Hip Arthroscopy
P-24.2.3 - dGEMRIC Analysis of Neoacetabular and Acetabular Cartilage of Patients with Developmental Dysplasia of the Hip
P-24.2.4 - Minimum 10-Year Follow-Up Outcomes and Survivorship Following Primary Hip Arthroscopy with Acetabular Microfracture